Association between puberty and features of nonalcoholic fatty liver disease
- PMID: 22343513
- PMCID: PMC3382041
- DOI: 10.1016/j.cgh.2012.01.020
Association between puberty and features of nonalcoholic fatty liver disease
Abstract
Background & aims: Physiological changes that occur during puberty might affect pathologic features of nonalcoholic fatty liver disease (NAFLD). We investigated associations between pubertal development and clinical and histopathologic features of NAFLD.
Methods: We studied 186 children (age <18 years, 143 boys) with biopsy-proven NAFLD. The population was divided into 3 groups on the basis of Tanner stage (prepuberty, puberty, and postpuberty). Clinical characteristics and histologic features were compared among groups. Multivariable regression models were used to adjust for potential confounders.
Results: After adjusting for other factors, hyperuricemia and low levels of high-density-lipoprotein cholesterol were more prevalent among children who entered puberty with lower levels of quantitative insulin sensitivity check index (P < .05). The degree of steatosis, numbers of Mallory-Denk bodies, and diagnostic categories of NAFLD differed among groups (P < .05). There were potential sex differences in associations between stages of puberty and lobular inflammation, hepatocyte ballooning, and borderline steatohepatitis of zone 3; these were therefore not included in multivariable analyses of the overall population. After adjustment for different sets of confounders, patients at or beyond puberty were less likely to have high-grade steatosis, severe portal inflammation, borderline steatohepatitis (zone 1), or a high stage of fibrosis than patients who had not entered puberty (P < .05). On the contrary, the prevalence of Mallory-Denk body was greater among postpuberty subjects (P = .06).
Conclusions: Steatosis, portal inflammation, and fibrosis are less severe during or after puberty than before puberty among subjects with NAFLD. Postpubescent individuals have a lower prevalence of borderline steatohepatitis of zone 1 but are more likely to have Mallory-Denk bodies. These findings indicate that puberty affects the pathologic features of NAFLD.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures

Similar articles
-
In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.Clin Gastroenterol Hepatol. 2018 Mar;16(3):438-446.e1. doi: 10.1016/j.cgh.2017.02.030. Epub 2017 Mar 7. Clin Gastroenterol Hepatol. 2018. PMID: 28286193 Free PMC article.
-
Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):190-7. doi: 10.1097/MPG.0b013e3181fb47d3. J Pediatr Gastroenterol Nutr. 2011. PMID: 21240012
-
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724. Hepatology. 2009. PMID: 19142989 Free PMC article.
-
Histopathology, grading and staging of nonalcoholic fatty liver disease.Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25. Minerva Gastroenterol Dietol. 2018. PMID: 28948754 Review.
-
Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research.Semin Liver Dis. 2012 Feb;32(1):3-13. doi: 10.1055/s-0032-1306421. Epub 2012 Mar 13. Semin Liver Dis. 2012. PMID: 22418883 Review.
Cited by
-
Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease.J Clin Endocrinol Metab. 2020 Nov 1;105(11):3496-504. doi: 10.1210/clinem/dgaa574. J Clin Endocrinol Metab. 2020. PMID: 32840311 Free PMC article.
-
Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.Gastroenterology. 2019 Dec;157(6):1448-1456.e1. doi: 10.1053/j.gastro.2019.08.048. Epub 2019 Sep 12. Gastroenterology. 2019. PMID: 31520612 Free PMC article. No abstract available.
-
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.Hepatology. 2019 Oct;70(4):1457-1469. doi: 10.1002/hep.30626. Epub 2019 Sep 23. Hepatology. 2019. PMID: 30924946 Free PMC article. Review.
-
Validation of attenuation imaging coefficient, shear wave elastography, and dispersion as emerging tools for non-invasive evaluation of liver tissue in children.Front Pediatr. 2023 Apr 17;11:1020690. doi: 10.3389/fped.2023.1020690. eCollection 2023. Front Pediatr. 2023. PMID: 37138563 Free PMC article.
-
A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.Clin Obes. 2021 Oct;11(5):e12472. doi: 10.1111/cob.12472. Epub 2021 Jun 9. Clin Obes. 2021. PMID: 34106515 Free PMC article.
References
-
- Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346:1221–31. - PubMed
-
- Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–93. - PubMed
-
- Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641–9. - PubMed
Publication types
MeSH terms
Grants and funding
- UL1RR02501401/RR/NCRR NIH HHS/United States
- U01DK061713/DK/NIDDK NIH HHS/United States
- U01 DK061732/DK/NIDDK NIH HHS/United States
- U01DK061731/DK/NIDDK NIH HHS/United States
- U01DK061737/DK/NIDDK NIH HHS/United States
- M01 RR000188/RR/NCRR NIH HHS/United States
- U01DK061718/DK/NIDDK NIH HHS/United States
- U01DK061728/DK/NIDDK NIH HHS/United States
- U01 DK061730/DK/NIDDK NIH HHS/United States
- U01 DK061728/DK/NIDDK NIH HHS/United States
- U01 DK061734/DK/NIDDK NIH HHS/United States
- M01RR020359/RR/NCRR NIH HHS/United States
- M01RR000827/RR/NCRR NIH HHS/United States
- U01DK061738/DK/NIDDK NIH HHS/United States
- UL1RR024128/RR/NCRR NIH HHS/United States
- U01 DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061713/DK/NIDDK NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- R01 DK074627/DK/NIDDK NIH HHS/United States
- U01 DK061731/DK/NIDDK NIH HHS/United States
- UL1RR02413101/RR/NCRR NIH HHS/United States
- U01 DK061718/DK/NIDDK NIH HHS/United States
- M01RR000065/RR/NCRR NIH HHS/United States
- UL1 RR024128/RR/NCRR NIH HHS/United States
- U01DK061732/DK/NIDDK NIH HHS/United States
- M01 RR000750/RR/NCRR NIH HHS/United States
- K23-DK062116/DK/NIDDK NIH HHS/United States
- M01 RR000065/RR/NCRR NIH HHS/United States
- K23 DK062116/DK/NIDDK NIH HHS/United States
- U01 DK061738/DK/NIDDK NIH HHS/United States
- UL1RR024989/RR/NCRR NIH HHS/United States
- M01 RR000827/RR/NCRR NIH HHS/United States
- M01RR00188/RR/NCRR NIH HHS/United States
- U01DK061734/DK/NIDDK NIH HHS/United States
- U01DK061730/DK/NIDDK NIH HHS/United States
- M01 RR020359/RR/NCRR NIH HHS/United States
- M01RR000750/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical